PDF(Pubmed)
Abstract：
UNASSIGNED: Despite the availability of effective antidepressant strategies, numerous people with depressive disorders remain untreated. The Covid-19 pandemic has affected healthcare services, especially the mental health sector. This study aims to explore the coverage of depression treatments in the general Spanish population and the impact of the Covid-19 pandemic.
UNASSIGNED: We used longitudinal data (2018 and 2022) from the general Spanish population: pre-pandemic n = 1512; mean age = 65.43 years ± 14.90; 56 % females; post-pandemic n = 909; mean age = 68.00 years ± 14.24; 54 % women. The International Classification of Disease 10th edition was used to diagnose lifetime depressive episodes and severity. We explored psychological and pharmacological treatment coverage via multiple logistic regressions adjusted for 4 covariates (sex assigned at birth, education level, age, Covid-19 pandemic) for participants with a diagnosis of depression.
UNASSIGNED: Treatment coverage for depression in the pre-pandemic and post-pandemic samples was, respectively, 53.3 % and 51.9 %. We observed an association between severe depression and treatment coverage (OR = 2.77, 95%CI 1.05 to 7.75). We found no association between the COVID-19 pandemic and treatment coverage.
UNASSIGNED: The pharmacological treatment coverage was associated with severe types of depression. The prevalence rates of treatment coverage were similar in the pre- and post-COVID-19 pandemic attesting to the resilience of the mental health system in Spain.
UNASSIGNED: We used longitudinal data (2018 and 2022) from the general Spanish population: pre-pandemic n = 1512; mean age = 65.43 years ± 14.90; 56 % females; post-pandemic n = 909; mean age = 68.00 years ± 14.24; 54 % women. The International Classification of Disease 10th edition was used to diagnose lifetime depressive episodes and severity. We explored psychological and pharmacological treatment coverage via multiple logistic regressions adjusted for 4 covariates (sex assigned at birth, education level, age, Covid-19 pandemic) for participants with a diagnosis of depression.
UNASSIGNED: Treatment coverage for depression in the pre-pandemic and post-pandemic samples was, respectively, 53.3 % and 51.9 %. We observed an association between severe depression and treatment coverage (OR = 2.77, 95%CI 1.05 to 7.75). We found no association between the COVID-19 pandemic and treatment coverage.
UNASSIGNED: The pharmacological treatment coverage was associated with severe types of depression. The prevalence rates of treatment coverage were similar in the pre- and post-COVID-19 pandemic attesting to the resilience of the mental health system in Spain.
摘要：
■尽管有有效的抗抑郁药策略，许多抑郁症患者仍未得到治疗。新冠肺炎大流行影响了医疗服务，尤其是精神卫生部门。这项研究旨在探讨西班牙普通人群抑郁症治疗的覆盖率以及新冠肺炎大流行的影响。
■我们使用了西班牙普通人群的纵向数据（2018年和2022年）：大流行前n=1512;平均年龄=65.43岁±14.90;56％女性;大流行后n=909;平均年龄=68.00岁±14.24;54％女性。国际疾病分类第10版用于诊断终生抑郁发作和严重程度。我们通过对4个协变量（出生时分配的性别，教育水平,年龄,Covid-19大流行)用于诊断为抑郁症的参与者。
■大流行前和大流行后样本中抑郁症的治疗覆盖率为，分别,53.3%和51.9%。我们观察到重度抑郁症与治疗覆盖率之间存在关联（OR=2.77，95CI1.05至7.75）。我们发现COVID-19大流行与治疗覆盖率之间没有关联。
■药物治疗范围与严重类型的抑郁症有关。在COVID-19大流行前后，治疗覆盖率的患病率相似，这证明了西班牙精神卫生系统的韧性。
■我们使用了西班牙普通人群的纵向数据（2018年和2022年）：大流行前n=1512;平均年龄=65.43岁±14.90;56％女性;大流行后n=909;平均年龄=68.00岁±14.24;54％女性。国际疾病分类第10版用于诊断终生抑郁发作和严重程度。我们通过对4个协变量（出生时分配的性别，教育水平,年龄,Covid-19大流行)用于诊断为抑郁症的参与者。
■大流行前和大流行后样本中抑郁症的治疗覆盖率为，分别,53.3%和51.9%。我们观察到重度抑郁症与治疗覆盖率之间存在关联（OR=2.77，95CI1.05至7.75）。我们发现COVID-19大流行与治疗覆盖率之间没有关联。
■药物治疗范围与严重类型的抑郁症有关。在COVID-19大流行前后，治疗覆盖率的患病率相似，这证明了西班牙精神卫生系统的韧性。
